The global dry eye syndrome market size is expected to reach USD 6.54 billion by 2027, exhibiting a CAGR of 4.7% during the forecast period. The increasing prevalence of chronic eye disorders and diseases will spur demand for eye treatment, which, in turn, will aid the expansion of the market.The global dry eye syndrome market size was USD 5.22 billion in 2019.
Get a Free Sample Research PDF: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/dry-eye-syndrome-market-102413
Weakened Dry Eye Drug Sales to Dampen Market Growth Amid COVID-19
The market players experienced a strong decline in dry eye drug sales. For instance, Novartis AG witnessed a decline of -31.4% in the revenue of its dry eye product Xiidra. The drug generated a revenue of US$ 104.0 Mn in a quarter second of 2019 whereas it generated US$ 79 Mn in the second quarter of 2020. The significant decline in the number of new eye examinations has further hindered the sales of such products. Moreover, lockdown in several countries has restricted the transportation and distribution of dry eye drugs, which, in turn, restrict the growth of the market amid coronavirus
The coronavirus incident has affected many industries and businesses around the world. The governments of several countries have instigated lockdown to thwart the spread of this deadly virus. Such plans have caused disturbances in the production and supply chain. But, with time and resolution, we will be able to combat this stern time and get back to normality. Our well-revised reports will help companies to receive in-depth information about the present scenario of every market so that you can adopt the necessary strategies accordingly.
The report on the dry eye syndrome market reveals:
- Exceptional insights into the market
- Systematic data with detailed analysis
- Market dynamics and aspects demonstrating the development
- Meticulous information about vital players in the market
- Imperative statistics about dominant regions
- COVID-19 affect
The Report Lists the Key Companies in the Dry Eye Syndrome Market:
- ALLERGAN (Dublin, Ireland)
- Alcon (Geneva, Switzerland)
- Novartis AG (Basel, Switzerland)
- Santen Pharmaceutical Co., Ltd. (Japan)
- OASIS Medical (California, U.S.)
- Sun Pharmaceutical Industries Ltd (Mumbai, India)
- Otsuka Pharmaceutical Co., Ltd. (Tokyo, Japan)
- Sentiss Pharma Pvt. Ltd. (Haryana, India)
- Johnson & Johnson Vision Care, Inc. (Jacksonville, U.S.)
- VISUfarma (Amsterdam, Netherlands)
- Other Prominent Players
Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/dry-eye-syndrome-market-102413
Some major points from Table of Content:
- Introduction
- Research Scope
- Market Segmentation
- Research Methodology
- Definitions and Assumptions
- Executive Summary
- Market Dynamics
- Market Drivers
- Market Restraints
- Market Opportunities
- Key Insights
- Prevalence Of Dry Eye Disease For Key Countries
- Key Industry Developments
- Pipeline Analysis
- New Product Launches
- Reimbursement Policies
- Regulatory Scenario
- Overview Of Novel Approaches To Treat Dry Eyes
- Key Industry Trends
- Healthcare Industry Overview
- Impact of COVID-19 on the Global Dry Eye Disease Treatment Market
- Overview of Over the Counter Eye Lubricants in the Market
- Global Dry Eye Syndrome Market Analysis, Insights and Forecast, 2016-2027
- Key Findings / Summary
- Market Analysis, Insights and Forecast – By Product Type
- Anti-inflammatory
- Cyclosporin
- Lifitegrast
- Corticosteroids
- Others
- Artificial Tears and Lubricants
- Anti-inflammatory
- Market Analysis, Insights and Forecast – By Distribution Channels
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Others
- Market Analysis, Insights and Forecast – By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
- North America Dry Eye Syndrome Market Analysis, Insights and Forecast, 2016-2027
- Key Findings / Summary
- Market Analysis – By Product Type
- Anti-inflammatory
- Cyclosporin
- Lifitegrast
- Corticosteroids
- Others
- Artificial Tears and Lubricants
- Anti-inflammatory
- Market Analysis – By Distribution Channels
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Others
- Market Analysis – By Country
- S.
Continued…
About Us:
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.